ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2019.0.227 2019.0.227 2020-03-312020-03-31general medical practice activities2019-04-01falsetruetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09140156 2019-04-01 2020-03-31 09140156 2018-04-01 2019-03-31 09140156 2020-03-31 09140156 2019-03-31 09140156 2018-04-01 09140156 1 2019-04-01 2020-03-31 09140156 d:Director3 2019-04-01 2020-03-31 09140156 c:CurrentFinancialInstruments 2020-03-31 09140156 c:CurrentFinancialInstruments 2019-03-31 09140156 c:CurrentFinancialInstruments c:WithinOneYear 2020-03-31 09140156 c:CurrentFinancialInstruments c:WithinOneYear 2019-03-31 09140156 c:ShareCapital 2019-04-01 2020-03-31 09140156 c:ShareCapital 2020-03-31 09140156 c:ShareCapital 2018-04-01 2019-03-31 09140156 c:ShareCapital 2019-03-31 09140156 c:ShareCapital 2018-04-01 09140156 c:CapitalRedemptionReserve 2019-04-01 2020-03-31 09140156 c:CapitalRedemptionReserve 2020-03-31 09140156 c:CapitalRedemptionReserve 2018-04-01 2019-03-31 09140156 c:CapitalRedemptionReserve 2019-03-31 09140156 c:CapitalRedemptionReserve 2018-04-01 09140156 c:RetainedEarningsAccumulatedLosses 2019-04-01 2020-03-31 09140156 c:RetainedEarningsAccumulatedLosses 2020-03-31 09140156 c:RetainedEarningsAccumulatedLosses 2018-04-01 2019-03-31 09140156 c:RetainedEarningsAccumulatedLosses 2019-03-31 09140156 c:RetainedEarningsAccumulatedLosses 2018-04-01 09140156 d:FRS102 2019-04-01 2020-03-31 09140156 d:AuditExempt-NoAccountantsReport 2019-04-01 2020-03-31 09140156 d:FullAccounts 2019-04-01 2020-03-31 09140156 d:PrivateLimitedCompanyLtd 2019-04-01 2020-03-31 iso4217:GBP xbrli:pure

Registered number: 09140156










SWALE COMMUNITY HEALTHCARE LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2020

 
SWALE COMMUNITY HEALTHCARE LIMITED
REGISTERED NUMBER: 09140156

BALANCE SHEET
AS AT 31 MARCH 2020

2020
2019
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 5 
53,027
144,097

Cash at bank and in hand
 6 
232,179
132,676

  
285,206
276,773

Creditors: amounts falling due within one year
 7 
(55,638)
(86,607)

Net current assets
  
 
 
229,568
 
 
190,166

Total assets less current liabilities
  
229,568
190,166

  

Net assets
  
229,568
190,166


Capital and reserves
  

Called up share capital 
  
39,418
34,732

Capital redemption reserve
  
1
1

Profit and loss account
  
190,149
155,433

  
229,568
190,166


Page 1

 
SWALE COMMUNITY HEALTHCARE LIMITED
REGISTERED NUMBER: 09140156
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2020

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Dr P Staker
Director

Date: 24 August 2020

The notes on pages 5 to 7 form part of these financial statements.

Page 2

 
SWALE COMMUNITY HEALTHCARE LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2020


Called up share capital
Capital redemption reserve
Profit and loss account
Total equity

£
£
£
£

At 1 April 2019
34,732
1
155,433
190,166


Comprehensive income for the year

Profit for the year

-
-
34,716
34,716


Other comprehensive income for the year
-
-
-
-


Total comprehensive income for the year
-
-
34,716
34,716

Shares issued during the year
4,686
-
-
4,686


Total transactions with owners
4,686
-
-
4,686


At 31 March 2020
39,418
1
190,149
229,568


The notes on pages 5 to 7 form part of these financial statements.

Page 3

 
SWALE COMMUNITY HEALTHCARE LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2019


Called up share capital
Capital redemption reserve
Profit and loss account
Total equity

£
£
£
£

At 1 April 2018
34,732
1
(12,019)
22,714


Comprehensive income for the year

Profit for the year

-
-
167,452
167,452


Other comprehensive income for the year
-
-
-
-


Total comprehensive income for the year
-
-
167,452
167,452


Total transactions with owners
-
-
-
-


At 31 March 2019
34,732
1
155,433
190,166


The notes on pages 5 to 7 form part of these financial statements.

Page 4

 
SWALE COMMUNITY HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2020

1.


General information

Swale Community Healthcare Limited is a private company, limited by shares, incorporated in England and Wales in the United Kingdom. The address of the registered office is c/o VWV, Narrow Quay House, Narrow Quay, Bristol, BS1 4QA.
The financial statements are presented in sterling, which is the functional currency of the company, and rounded to the nearest £1. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The accounts have been prepared on the going concern basis, however there is a possibility the company may close as detailed in the Post Balance Sheet Events note.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Finance costs

Finance costs are charged to the Statement of Income and Retained Earnings over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 5

 
SWALE COMMUNITY HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2020

2.Accounting policies (continued)

 
2.5

Taxation

Tax is recognised in the Statement of Income and Retained Earnings, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.6

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in the case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.


3.


Judgements in applying accounting policies and key sources of estimation uncertainty

No significant judgements have been made by management in preparing these financial statements.

Page 6

 
SWALE COMMUNITY HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2020

4.


Employees

The average monthly number of employees, including directors, during the year was 0 (2019 - 0).


5.


Debtors

2020
2019
£
£


Trade debtors
53,027
144,087

Called up share capital not paid
-
10

53,027
144,097



6.


Cash and cash equivalents

2020
2019
£
£

Cash at bank and in hand
232,179
132,676

232,179
132,676



7.


Creditors: Amounts falling due within one year

2020
2019
£
£

Trade creditors
45,188
46,317

Corporation tax
8,143
38,038

Other creditors
432
432

Accruals and deferred income
1,875
1,820

55,638
86,607



8.


Post balance sheet events

Due to the emergence of Primary Care Networks (PCNs), there may no longer be a need for the company, and therefore there is a possibility the company will close.

 
Page 7